Paying users zone. Data is covered by hidden.

  • Get 1 month access to Thermo Fisher Scientific Inc. for $17.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Thermo Fisher Scientific Inc. (TMO)


Statement of Cash Flows

Difficulty: Beginner

The cash flow statement provides information about a company’s cash receipts and cash payments during an accounting period, showing how these cash flaws link the ending cash balance to the beginning balance shown on the company’s statement of financial position.

The cash flow statement consists of three parts: cash flows provided by (used in) operating activities, cash flows provided by (used in) investing activities, and cash flows provided by (used in) financing activities.

Thermo Fisher Scientific Inc., Consolidated Statement of Cash Flows

USD $ in millions

Microsoft Excel LibreOffice Calc
12 months ended Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Net income hidden hidden hidden hidden hidden
Loss from discontinued operations hidden hidden hidden hidden hidden
Income from continuing operations hidden hidden hidden hidden hidden
Depreciation and amortization hidden hidden hidden hidden hidden
Change in deferred income taxes hidden hidden hidden hidden hidden
Net gains on sale of businesses hidden hidden hidden hidden hidden
Non-cash stock-based compensation hidden hidden hidden hidden hidden
Tax benefits from stock-based compensation awards hidden hidden hidden hidden hidden
Other non-cash expenses, net hidden hidden hidden hidden hidden
Accounts receivable hidden hidden hidden hidden hidden
Inventories hidden hidden hidden hidden hidden
Other assets hidden hidden hidden hidden hidden
Accounts payable hidden hidden hidden hidden hidden
Other liabilities hidden hidden hidden hidden hidden
Contributions to retirement plans hidden hidden hidden hidden hidden
Changes in assets and liabilities, excluding the effects of acquisitions and dispositions hidden hidden hidden hidden hidden
Adjustments to reconcile income from continuing operations to net cash provided by operating activities hidden hidden hidden hidden hidden
Net cash provided by operating activities hidden hidden hidden hidden hidden
Acquisitions, net of cash acquired hidden hidden hidden hidden hidden
Proceeds from sale of businesses, net of cash divested hidden hidden hidden hidden hidden
Purchase of property, plant and equipment hidden hidden hidden hidden hidden
Proceeds from sale of property, plant and equipment hidden hidden hidden hidden hidden
(Increase) decrease in restricted cash hidden hidden hidden hidden hidden
Other investing activities, net hidden hidden hidden hidden hidden
Net cash used in investing activities hidden hidden hidden hidden hidden
Net proceeds from issuance of debt hidden hidden hidden hidden hidden
Repayment of debt hidden hidden hidden hidden hidden
Proceeds from issuance of commercial paper hidden hidden hidden hidden hidden
Repayments of commercial paper hidden hidden hidden hidden hidden
Increase in short-term notes payable hidden hidden hidden hidden hidden
Purchases of company common stock hidden hidden hidden hidden hidden
Dividends paid hidden hidden hidden hidden hidden
Net proceeds from issuance of company common stock hidden hidden hidden hidden hidden
Net proceeds from issuance of company common stock under employee stock plans hidden hidden hidden hidden hidden
Tax benefits from stock-based compensation awards hidden hidden hidden hidden hidden
Other financing activities, net hidden hidden hidden hidden hidden
Net cash provided by (used in) financing activities hidden hidden hidden hidden hidden
Net cash used in discontinued operating activities hidden hidden hidden hidden hidden
Net cash provided by (used in) discontinued operations hidden hidden hidden hidden hidden
Exchange rate effect on cash hidden hidden hidden hidden hidden
Increase (decrease) in cash, cash equivalents and restricted cash hidden hidden hidden hidden hidden
Cash, cash equivalents and restricted cash at beginning of period hidden hidden hidden hidden hidden
Cash, cash equivalents and restricted cash at end of period hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-28), 10-K (filing date: 2017-02-28), 10-K (filing date: 2016-02-25), 10-K (filing date: 2015-02-26).

Item Description The company
Net cash provided by operating activities Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Thermo Fisher Scientific Inc.’s net cash provided by operating activities increased from 2016 to 2017 and from 2017 to 2018.
Net cash used in investing activities Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets. Thermo Fisher Scientific Inc.’s net cash used in investing activities declined from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Net cash provided by (used in) financing activities Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit. Thermo Fisher Scientific Inc.’s net cash provided by (used in) financing activities increased from 2016 to 2017 but then declined significantly from 2017 to 2018.